Top news of the week: 07.07.2020.
Biotechnology, Health care, Pharmacology, Antibody, Medicine, Vaccination
Healthcare
BioSpace Movers & Shakers, July 3
Biopharma and life sciences companies bolster their executive teams and board with these Movers & Shakers.
British cell therapy biotech Rexgenero nabs life science veteran as CMO #BioTech #ui via https://t.co/2sI0UxJbpn https://t.co/ldnjPswxee
OpenBritish cell therapy biotech Rexgenero nabs life science veteran as CMO
With stints at the likes of Genzyme, Bayer and, most recently, TranScrip Partners, Gilbert Wagener, M.D., Ph.D., is now signing up to U.K. biotech Rexgenero.
Takeda pens $900M biobucks pact with Carmine for non-viral gene therapy work #BioTech via https://t.co/2sI0UxJbpn https://t.co/73XOJVYKRY
OpenTakeda pens $900M biobucks pact with Carmine for non-viral gene therapy work
Japanese pharma and biotech friend Takeda is set to spend nearly $1 billion in backloaded payments for a deal with early-stage startup Carmine Therapeutics.
Bolt Biotherapeutics Pushes Forward with Initiatives Following $93.5 Million Series C https://t.co/fsrKnw2GN2 https://t.co/uhIq4emceU
OpenBolt Biotherapeutics Pushes Forward with Initiatives Following $93.5 Million Series C
Clinical-stage biotechnology company Bolt Biotherapeutics announced today that it has completed a $93.5 million Series C round of financing, led by Sofinnova Investments.
Pfizer and BioNTech’s COVID-19 Vaccine Shows Early Positive Data https://t.co/ZoQjE8Au8V https://t.co/04Px8Hqmjb
OpenPfizer and BioNTech’s COVID-19 Vaccine Shows Early Positive Data
Pfizer and BioNTech indicate that this data, along with preclinical data and additional data being generated, will be leveraged to choose a dose level and pick the best vaccine candidate ...
RT @airnewsalerts: PGIMS, Rohtak to go for clinical trial of Covaxin vaccine prepared by Bharat Biotech
https://t.co/x8q939SK5b
OpenPGIMS, Rohtak to go for clinical trial of Covaxin vaccine prepared by Bharat Biotech
In Haryana, Post Graduate Institute of Medical Sciences in Rohtak will go for clinical trial of Covaxin vaccine prepared by Bharat Biotech for Novel Corona virus in coordination.
"It's been delayed," said @CarlosdelRio7. "We won't start until July 27, probably. But July 27 would still be absolutely amazing. Even if it happens in early August, that's still amazing. This is going at a speed no other vaccine has ever gone."
https://t.co/rF4Xv9S4x5
OpenCoronavirus vaccines: 'Encouraging' early data for some, a trial delay for another and more research ahead
Scientists around the world are racing to develop Covid-19 vaccines and there's news almost daily about steps forward -- this week, there was "encouraging" preliminary data for some ...
RT @thenewsminute: ICMR and Bharat Biotech want to launch indigenous COVID-19 vaccine by Aug 15 https://t.co/2fcxRGkQgr
OpenICMR and Bharat Biotech want to launch indigenous COVID-19 vaccine by Aug 15
The Indian Council for Medical Research said that wants to launch India’s indigenous COVID-19 vaccine, COVAXIN, for public use by August 15. For this purpose, 12 institutes were selected on ...